NOVO NORDISK
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
NOVO NORDISK
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1923-01-01
Address:
Bagsværd, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.novonordisk.com
Total Employee:
10001+
Status:
Active
Contact:
+45 44 44 88 88
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Apache Global Site Tag Nginx
Similar Organizations
Angelini Pharma
Angelini Pharma specializes in healthcare, with particular expertise in the fields of mental health, pain and inflammation, and pediatrics.
apomio
apomio is a German pharmacy and drug price comparison website that allows patients to submit adverse reactions and rate pharmacies.
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
BIOTRONIK
Biotronik is a privately held multinational biomedical technology company headquartered in Berlin, Germany.
Breas Medical
Breas Medical AB, a member of the GE Healthcare group, was founded in Gothenburg, Sweden in 1991 and has continued to expand during two
Desitin Arzneimittel
Desitin Arzneimittel is a European pharmaceutical company specializes in products for the therapy of neurological and psychiatric diseases.
Eu Yan Sang Singapore
Eu Yan Sang is Asia's leading integrative healthcare and wellness company with a strong foundation in Traditional Chinese medicine.
Laboratoires Genevrier
Laboratoires Genevrier engages in improving human health by offering an extensive range of innovative and effective pharmaceutical products.
Lacer
Lacer is a Spanish company with an international scope in human healthcare.
Me Cure
Me Cure is the fastest growing healthcare company in West Africa; we have medical imaging diagnostic centers in alliance with GE.
Okyo Pharma
Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.
PDP Couriers
PDP Couriers is a truly global specialist courier for clinical trials, transport of clinical and medical research and logistics management.
PharmaCord
PharmaCord is a healthcare company that provides innovative solutions that drive efficient and rapid access to life saving therapies.
Real Chemistry
Real Chemistry is a global health innovation company committed to making the world a healthier place for all.
Ryvu
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Schering AG
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
Seqens
Seqens is a integrated in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness.
SkyePharma
SkyePharma is a speciality drug delivery company with a range of oral and inhalation technologies.
Synovo GmbH
Synovo GmbH is a drug discovery company with a primary focus on inflammation and innate immune processes
Tebu Bio
Supplying a comprehensive range of innovative and convenient reagents and lab services to European Life Scientists.
UPSA SAS
UPSA SAS specialists in the fight against pain and self-medication.
Vygon (UK)
Vygon is a developer and supplier of medical and surgical disposables company.
Wockhardt Germany GmbH
Wockhardt Germany GmbH is offers prescription drugs for urology and neurology disorders and diabetes.
Yliopiston Apteekki
Yliopiston Apteekki is an online store that offers a wide range of medicine, cosmetics, vitamins and nutritional supplements.
Current Advisors List
Board_member
Board_member
2020-11-01
Board_member
Advisor
2020-01-01
Advisor
Board_member
2020-02-01
Board_member
Current Employees Featured
Marianne Hedegaard Service Manager (eDevice/eSolution in Clinical Trials) @ Novo Nordisk
Service Manager (eDevice/eSolution in Clinical Trials)
2019-10-01
Maziar Mike Doustdar Executive Vice President, International Operations @ Novo Nordisk
Executive Vice President, International Operations
2016-09-01
Maura Reilly Associate Director @ Novo Nordisk
Associate Director
2020-04-01
Monique Carter EVP People & Organisation @ Novo Nordisk
EVP People & Organisation
2019-08-01
Henrik Gürtler Corporate Vice President of Human Resource Development @ Novo Nordisk
Corporate Vice President of Human Resource Development
Greg Jones Vice President, Legal Affairs @ Novo Nordisk
Vice President, Legal Affairs
2015-10-01
Christian Wenzel Tornøe Principal Scientist @ Novo Nordisk
Principal Scientist
Jørgen Boe Project Director @ Novo Nordisk
Project Director
2016-04-01
Jesper HØiland EVP, Novo Nordisk USA @ Novo Nordisk
EVP, Novo Nordisk USA
Karsten Munk Knudsen Executive vice president & CFO @ Novo Nordisk
Executive vice president & CFO
2018-02-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-01 | FORMA Therapeutics | FORMA Therapeutics acquired by Novo Nordisk | 1.1 B USD |
| 2021-11-18 | Dicerna Pharmaceuticals | Dicerna Pharmaceuticals acquired by Novo Nordisk | 3.3 B USD |
| 2020-11-06 | Emisphere Technologies | Emisphere Technologies acquired by Novo Nordisk | 1.35 B USD |
| 2020-06-11 | Corvidia | Corvidia acquired by Novo Nordisk | 725 M USD |
| 2018-08-17 | Ziylo | Ziylo acquired by Novo Nordisk | N/A |
| 2015-08-27 | MB2 | MB2 acquired by Novo Nordisk | N/A |
| 2015-08-27 | Calibrium | Calibrium acquired by Novo Nordisk | N/A |
| 2013-05-21 | Xellia Pharmaceuticals | Xellia Pharmaceuticals acquired by Novo Nordisk | 700 M USD |
| 2003-10-01 | Aldaph SpA | Aldaph SpA acquired by Novo Nordisk | N/A |
| 1988-01-01 | ZymoGenetics | ZymoGenetics acquired by Novo Nordisk | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-17 | Beta Bionics | Novo Nordisk investment in Series C - Beta Bionics | 57 M USD |
| 2021-03-16 | Glooko | Novo Nordisk investment in Series D - Glooko | 30 M USD |
| 2020-09-24 | Sundew | Novo Nordisk investment in Seed Round - Sundew | 1.51 M EUR |
| 2016-01-05 | IO Biotech | Novo Nordisk investment in Series A - IO Biotech | 11 M EUR |
| 2015-12-31 | Beta Bionics | Novo Nordisk investment in Series A - Beta Bionics | 5 M USD |
| 2010-04-29 | Affimed | Novo Nordisk investment in Series C - Affimed | 20 M EUR |
| 2008-09-03 | Osprey Pharmaceuticals USA | Novo Nordisk investment in Series A - Osprey Pharmaceuticals USA | 11 M USD |
| 2007-10-25 | Xencor | Novo Nordisk investment in Series E - Xencor | 15 M USD |
| 2004-09-01 | Innate Pharma | Novo Nordisk investment in Series C - Innate Pharma | 15 M EUR |
| 2003-02-07 | TransTech Pharma | Novo Nordisk investment in Venture Round - TransTech Pharma | 24.5 M USD |
Newest Events participated
Official Site Inspections
http://www.novonordisk.com Semrush global rank: 224.79 K Semrush visits lastest month: 324.03 K
- Host name: 52.166.181.85
- IP address: 52.166.181.85
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Novo Nordisk"
Corporate governance - Novo Nordisk
Novo Nordisk’s B shares are listed on Nasdaq Copenhagen and on the New York Stock Exchange (NYSE) as American Depository Receipts (ADRs). Novo Nordisk reports on the Danish Corporate Governance Recommendations designated …See details»
Novo Nordisk Canada
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.See details»
Executive Management - Novo Nordisk
Executive remuneration is governed by the applicable Remuneration Policy adopted at the Annual General Meeting, while the Remuneration Principles adopted by the Annual General Meeting in 2019 still governs long term …See details»
Novo Nordisk - Wikipedia
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares. See details»
Novo Nordisk Org Chart + Executive Team - The Official Board
Novo Nordisk Org Chart www.novonordisk.com. has 184 executives and 16 subsidiaries +45 4444 8888; Add an executive. Novo Nordisk (NOVO) News ... Unfortunately, you don't own …See details»
Novo Nordisk - The Org
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, …See details»
Novo Nordisk - Crunchbase Company Profile & Funding
Contact Email prindia@novonordisk.com; Phone Number +45 44 44 88 88; Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat …See details»
Board of Directors - Novo Nordisk Annual Report 2024
Participants at the 2024 World Panna Championships in Copenhagen, Denmark. ‘Panna’ is an increasingly popular type of street football, and the Pannahouse organisation champions physical and mental health, cultural understanding …See details»
Purpose and strategy - Novo Nordisk Annual Report …
At Novo Nordisk, our purpose is clear: driving change to defeat serious chronic diseases.Through our life-changing innovations, we are building a healthier future for generations to come. We are dedicated to reinforcing our leadership in …See details»
Who we are - Novo Nordisk
Our story starts in 1923 when two small Danish companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.. When at last they decided to merge in 1989, they …See details»
Who we are - Novo Nordisk
Our story starts in 1923 when two small Danish companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.. …See details»
Letter from the Chair and the CEO - Novo Nordisk Annual Report …
2024 was a year of significant growth for Novo Nordisk, characterised by continued innovation, capacity expansions and strong commercial execution.As we reflect on our progress, we also …See details»
Novo Nordisk announces changes in Executive Management
Apr 3, 2025 Novo Nordisk employs about 76,300 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen …See details»
Novo Nordisk, Inc. - amga.org
If you are an organization that provides healthcare, you can join AMGA as a member. Learn More. ... Jgai@novonordisk.com (502) 727-9549. About. Novo Nordisk is a leading global healthcare …See details»
Novo Nordisk Company Profile Revealed: Inside Look
Website: https://www.novonordisk.com Industry Sector : Healthcare - Biotechnology Full Time Employees: 54,393 Annual Revenue: 176.95B (DKK) ... Novo Nordisk Org Chart - Executive …See details»
CORPORATE GOVERNANCE - novonordisk.com
CORPORATE GOVERNANCE REPORT 2024 Novo Nordisk A/S – Novo Alle 1, 2880 Bagsværd, Denmark – CVR no. 24256790 A Novo Nordisk employee receiving a tour of our active …See details»
Value creation - Novo Nordisk Annual Report 2024
Harish Manikandan lives with obesity in Chile. Harish maintains an active lifestyle in the bustling city of Santiago and, amid his daily duties as head chef at a restaurant, finds tranquility on his …See details»
Novo Nordisk - Global Health Progress
Novo Nordisk is a global healthcare company with 100 years of experience in innovation and leadership in diabetes care. Our purpose is to drive change to defeat diabetes and other …See details»
What we do - Novo Nordisk
Discovering, developing and delivering. For more than 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines …See details»
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to …
Mar 25, 2025 Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors' perception of the health care system is improving.See details»